Seres Therapeutics, Inc. (NASDAQ:MCRB) Receives Average Recommendation of “Hold” from Brokerages
Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating on the company. The […]
Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating on the company. The […]
